EIM
RARE icon

Essex Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Essex Investment Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,481
Closed -$52.8K – 363
2023
Q3 		$52.8K Sell
1,481
-13
-0.9% -$515 0.01% 313
2023
Q2 		$68.9K Hold
1,494
– – 0.01% 315
2023
Q1 		$59.9K Sell
1,494
-18
-1% -$772 0.01% 320
2022
Q4 		$70K Hold
1,512
– – 0.01% 313
2022
Q3 		$63K Hold
1,512
– – 0.01% 311
2022
Q2 		$90K Sell
1,512
-1,170
-44% -$72K 0.01% 315
2022
Q1 		$195K Buy
2,682
+348
+15% +$24.2K 0.02% 302
2021
Q4 		$196K Sell
2,334
-365
-14% -$29.7K 0.02% 310
2021
Q3 		$243K Hold
2,699
– – 0.03% 309
2021
Q2 		$257K Sell
2,699
-89
-3% -$9.27K 0.03% 317
2021
Q1 		$317K Buy
2,788
+395
+17% +$53.8K 0.04% 316
2020
Q4 		$331K Hold
2,393
– – 0.04% 317
2020
Q3 		$197K Buy
+2,393
New +$198K 0.03% 355
2016
Q2 		– Sell
-7,512
Closed -$476K – 337
2016
Q1 		$476K Buy
+7,512
New +$492K 0.08% 235

Other funds holding RARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Essex Investment Management's RARE Position: Q4 2023 in Review

Essex Investment Management sold out of Ultragenyx Pharmaceutical (RARE) in Q4 2023, closing a stake of 1,481 shares — an estimated $52.8K sold.

Essex Investment Management first reported a position in RARE in Q1 2016 and held it in 14 quarters. The position peaked at $476K in Q1 2016. 237 funds tracked by Wall St. Rank hold RARE as of Q4 2023.

  • Essex Investment Management reported no remaining Ultragenyx Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Essex Investment Management sold 1,481 Ultragenyx Pharmaceutical shares in Q4 2023, an estimated $52.8K.
  • Essex Investment Management first reported a position in Ultragenyx Pharmaceutical in Q1 2016 and held it in 14 quarters.
  • Essex Investment Management's Ultragenyx Pharmaceutical position peaked at $476K in Q1 2016.
  • 237 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2023.

Based on Essex Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.